Tatara Therapeutics

Tatara is a venture-funded biotechnology company working to exploit ferroptosis and ferro-addiction to better target tumors. The company is developing a pipeline of in vivo active leads based on proprietary iron-activated drug conjugate (FeADC™) technology.